Symbol
| KLK1
| contributors: mct - updated : 16-04-2020
|
HGNC name
| kallikrein 1
|
HGNC id
| 6357
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
decreased in renal clear cell carcinoma | constitutional
|  
|  
| --low
|  
|
decreased KLK1 expression in Chronic obstructive pulmonary disease (COPD) patients could contribute to the worsening of influenza | constitutional
|  
|  
|  
| gain of function
|
in tubular epithelial cells that may mediate pro-inflammatory pathway and F2RL3 activation during diabetic nephropathy | constitutional
|  
|  
| --over
|  
|
by astrocytes in the hippocampus of patients with refractory temporal lobe epilepsy, associated with hippocampal sclerosis | |
Susceptibility
|
to hypertension and/or hypertension asociated with end- stage renal disease to aortic aneurysm (AA) to coronary artery stenosis (CAS) |
Variant & Polymorphism
SNP
| KLK1 rs5516 G allele is closely associated with AA |
|
polymorphism of the KLK1 A1789G gene is associated with CAS |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
reproduction | fertility | | |
targets for the treatment of azoospermia |
| | | |
| inactivating the Klk1 gene or treating WT mice with an anti-Klk1 monoclonal antibody to remove Klk1 activity accelerated the initial virus-induced apoptotic depletion of alveolar macrophages |